ATE323532T1 - Nicht-peptidische ccr1-rezeptor-antagonisten zur behandlung der progressiven nierenfibrose - Google Patents

Nicht-peptidische ccr1-rezeptor-antagonisten zur behandlung der progressiven nierenfibrose

Info

Publication number
ATE323532T1
ATE323532T1 AT02756960T AT02756960T ATE323532T1 AT E323532 T1 ATE323532 T1 AT E323532T1 AT 02756960 T AT02756960 T AT 02756960T AT 02756960 T AT02756960 T AT 02756960T AT E323532 T1 ATE323532 T1 AT E323532T1
Authority
AT
Austria
Prior art keywords
renal fibrosis
peptidic
treatment
receptor antagonists
progressive renal
Prior art date
Application number
AT02756960T
Other languages
English (en)
Inventor
Richard Horuk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE323532T1 publication Critical patent/ATE323532T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02756960T 2001-08-07 2002-08-05 Nicht-peptidische ccr1-rezeptor-antagonisten zur behandlung der progressiven nierenfibrose ATE323532T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31053801P 2001-08-07 2001-08-07
US10/205,713 US6812230B2 (en) 2001-08-07 2002-07-26 Non-peptide CCR1 receptor antagonists for the treatment of progressive renal fibrosis

Publications (1)

Publication Number Publication Date
ATE323532T1 true ATE323532T1 (de) 2006-05-15

Family

ID=26900695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02756960T ATE323532T1 (de) 2001-08-07 2002-08-05 Nicht-peptidische ccr1-rezeptor-antagonisten zur behandlung der progressiven nierenfibrose

Country Status (10)

Country Link
US (1) US6812230B2 (de)
EP (1) EP1423166B1 (de)
JP (1) JP2005501084A (de)
AT (1) ATE323532T1 (de)
CY (1) CY1105302T1 (de)
DE (1) DE60210783T2 (de)
DK (1) DK1423166T3 (de)
ES (1) ES2261709T3 (de)
PT (1) PT1423166E (de)
WO (1) WO2003013656A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011216A2 (en) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
NZ619918A (en) * 2008-10-21 2015-04-24 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2771484A1 (de) 2011-10-28 2014-09-03 Galderma Research & Development Neue leukozyteninfiltratmarker für rosacea und verwendungen davon
WO2014130648A1 (en) 2013-02-20 2014-08-28 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
GB201918692D0 (en) 2019-12-18 2020-01-29 Cambridge Entpr Ltd Treatment and prognosis of pancreatic cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
UA73553C2 (en) * 2000-03-31 2005-08-15 Pfizer Prod Inc Piperazine derivatives

Also Published As

Publication number Publication date
EP1423166A2 (de) 2004-06-02
DE60210783T2 (de) 2007-04-12
PT1423166E (pt) 2006-08-31
JP2005501084A (ja) 2005-01-13
ES2261709T3 (es) 2006-11-16
DK1423166T3 (da) 2006-08-21
WO2003013656A3 (en) 2003-05-01
DE60210783D1 (de) 2006-05-24
EP1423166B1 (de) 2006-04-19
CY1105302T1 (el) 2010-03-03
WO2003013656A2 (en) 2003-02-20
US6812230B2 (en) 2004-11-02
US20030109534A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
EP1337249A4 (de) Zusammensetzungen und verfahren zur verabreichung von pharmakologisch aktiven verbindungen
GEP20084571B (en) Triazole derivatives as vasopressin antagonists
EP1615914A4 (de) Cgrp-rezeptorantagonisten
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
WO2006038006A3 (en) 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders
WO2002060392A3 (en) Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
EA200201276A1 (ru) Производные арилметиламина для использования в качестве ингибиторов триптазы
MY133503A (en) Selective iglur5 receptor antagonists for the treatment of migrane
CY1105302T1 (el) Μη-πεπτιδιο ανταγωνιστες υποδοχεα ccr1 για την θepαπεια προϊουσης νεφρικης ινωσης
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
EA200400302A1 (ru) Способ лечения первичной бессонницы
MXPA04008460A (es) Composiciones farmaceuticas de un inhibidor de pde4 o pde3/4 y un antagonista de receptor de histamina.
NO20013459L (no) Anvendelse av angiotensin II reseptorantagonister ved behandling av akutt myokardinfarkt
CY1105321T1 (el) Μη πεπτιδικοι ανταγωνιστες υποδοχεα ccr1 σε συνδυασμο με κυκλοσπορινη α για τη θepαπεια της απορριψης καρδιακου μοσχευματος
YU60803A (sh) Upotreba antagonista gal3 receptora u lečenju depresije i/ili uznemirenosti i jedinjenja korisna u tim postupcima
DE60137451D1 (de) N-substituierte Amide als NK1 Rezeptor Antagonisten
LT2003015A (en) Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1423166

Country of ref document: EP

REN Ceased due to non-payment of the annual fee